Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vardenafil for symptomatic benign prostatic hyperplasia
2005-002796-32Phase 2Completed
- Sponsor
- Bayer
- Start
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in benign prostatic hyperplasia (BPH) comparing Vardenafil 10 mg BID with Placebo (2 arms). Primary endpoint: Primary efficacy endpoints. Started Oct 2005; status: completed.
02
Drugs
vardenafil
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on 2005-002796-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002796-32.